NS
Neeraja Shantaram Shetty
About Neeraja Shantaram Shetty
Data last updated:
Neeraja Shantaram Shetty was a Ceo(Kmp) at Sami-Sabinsa Group Limited (2012–2022), Director at Hampton Pharma Private Limited (2008–2011) and Additional Director at Edappallil Family Services Private Limited (2022), and held 3 more directorships. The companies operate in Healthcare, Pharma and Business Services.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo(Kmp) | 02 Jul 2012 | 1991 | ₹1,137 Cr (FY 2025) | Active | |
| Director | 05 Feb 2008 | 2008 | ₹1.90 Cr (FY 2017) | Active | |
| Additional Director | 04 Jan 2022 | 2021 | Active | ||
| Director | 05 Feb 2008 | 2008 | ₹4.42 Cr (FY 2021) | Active | |
| Director | 25 Jul 2020 | 2020 | ₹18.00 Cr (FY 2025) | Active | |
| Director | 17 Jun 2022 | 2022 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neeraja Shantaram Shetty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neeraja Shantaram Shetty
Neeraja Shantaram Shetty was first appointed on 05 Feb 2008 as Director at Hampton Pharma Private Limited. The most recent appointment on record is 17 Jun 2022 at Triyah Wellness Private Limited.
Neeraja Shantaram Shetty held 6 earlier board appointments: Sami-Sabinsa Group Limited (Ceo(Kmp), 02 Jul 2012 to 07 Feb 2022); Hampton Pharma Private Limited (Director, 05 Feb 2008 to 18 Oct 2011); Edappallil Family Services Private Limited (Additional Director, 04 Jan 2022 to 07 Feb 2022); Igenerix Pharma Private Limited (Director, 05 Feb 2008 to 18 Oct 2011); Sami Nutraceuticals Private Limited (Director, 25 Jul 2020 to 07 Feb 2022); and 1 more.